RNA‑seq analyses of antibiotic resistance mechanisms in Serratia marcescens

Li,Zhaodong; Xu,Meihua; Wei,Hui; Wang,Lili; Deng,Min

doi:10.3892/mmr.2019.10281

RNA‑seq analyses of antibiotic resistance mechanisms in Serratia marcescens

Authors:
- Zhaodong Li
- Meihua Xu
- Hui Wei
- Lili Wang
- Min Deng
View Affiliations

Affiliations: Clinical Laboratory, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang 310004, P.R. China, Emergency Department, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang 310004, P.R. China
Published online on: May 22, 2019 https://doi.org/10.3892/mmr.2019.10281
Pages: 745-754
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to further clarify the genetic mechanisms responsible for the antimicrobial resistance of Serratia marcescens (S. marcescens) using RNA sequencing. Three drug‑susceptible S. marcescens strains (named MYQT1, MYQT2, and MYQT3) and three multidrug‑resistant S. marcescens strains (named MYQT4, MYQT5, and MYQT6) were isolated from six different patients and subjected to RNA sequencing. Differentially expressed genes (DEGs) between the multidrug‑resistant S. marcescens strains and drug‑susceptible strains were screened and compared, followed by functional enrichment analysis. In addition, a protein‑protein interaction (PPI) network was constructed, and significant modules were extracted from it. Genes enriched in the significant modules were subjected to further enrichment analysis. MYQT3 had very a different expression pattern from MYQT1 and MYQT2, and thus, MYQT3 was excluded from the following analysis. A total of 225 DEGs were identified, of which SMDB11_RS09300 (GTP cyclohydrolase FolE2) was the most significantly upregulated with a log2 FC of 6.4; these DEGs were enriched in different GO terms, including hydrogen sulfide biosynthetic process, sulfur compound transmembrane transporter activity, and ABC transporter complex. Additionally, several genes were identified to be important genes in the PPI network, including SMDB11_RS17755 (upregulated; glutamate synthase large subunit), SMDB11_RS00590 (upregulated; sulfite reductase subunit α), and SMDB11_RS04505 (upregulated; cystathionine β‑synthase). Thus, SMDB11_RS09300, SMDB11_RS17755, SMDB11_RS00590, and SMDB11_RS04505 may play significant roles in the antimicrobial resistance of S. marcescens by participating in folate metabolism or the integrity of cell membranes. However, further experiments are required to clarify these findings.

View Figures

View References

1	Courtney CM, Goodman SM, McDaniel JA, Madinger NE, Chatterjee A and Nagpal P: Photoexcited quantum dots for killing multidrug-resistant bacteria. Nat Mater. 15:529–534. 2016. View Article : Google Scholar : PubMed/NCBI
2	Iguchi A, Nagaya Y, Pradel E, Ooka T, Ogura Y, Katsura K, Kurokawa K, Oshima K, Hattori M, Parkhill J, et al: Genome evolution and plasticity of Serratia marcescens, an important multidrug-resistant nosocomial pathogen. Genome Biol Evol. 6:2096–2110. 2014. View Article : Google Scholar : PubMed/NCBI
3	Blair JM, Webber MA, Baylay AJ, Ogbolu DO and Piddock LJ: Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol. 13:42–51. 2015. View Article : Google Scholar : PubMed/NCBI
4	Alekshun MN and Levy SB: Molecular mechanisms of antibacterial multidrug resistance. Cell. 128:1037–1050. 2007. View Article : Google Scholar : PubMed/NCBI
5	Ma XJ, Yang HF, Liu YY, Mei Q, Ye Y, Li HR, Cheng J and Li JB: The emergence of the 16S rRNA methyltransferase RmtB in a multidrug-resistant Serratia marcescens isolate in China. Ann Lab Med. 35:172–174. 2015. View Article : Google Scholar : PubMed/NCBI
6	Su W, Zhu Y, Deng N and Li L: Imipenem-resistance in Serratia marcescens is mediated by plasmid expression of KPC-2. Eur Rev Med Pharmacol Sci. 21:1690–1694. 2017.PubMed/NCBI
7	Olaitan AO, Morand S and Rolain JM: Mechanisms of polymyxin resistance: Acquired and intrinsic resistance in bacteria. Front Microbiol. 5:6432014. View Article : Google Scholar : PubMed/NCBI
8	Rabbani B, Nakaoka H, Akhondzadeh S, Tekin M and Mahdieh N: Next generation sequencing: Implications in personalized medicine and pharmacogenomics. Mol Biosyst. 12:1818–1830. 2016. View Article : Google Scholar : PubMed/NCBI
9	Crofts TS, Gasparrini AJ and Dantas G: Next-generation approaches to understand and combat the antibiotic resistome. Nat Rev Microbiol. 15:422–434. 2017. View Article : Google Scholar : PubMed/NCBI
10	Crowley E, Bird P, Fisher K, Goetz K, Boyle M, Benzinger MJ Jr, Juenger M, Agin J, Goins D and Johnson R: Evaluation of the VITEK 2 Gram-negative (GN) microbial identification test card: Collaborative study. J AOAC Int. 95:778–785. 2012. View Article : Google Scholar : PubMed/NCBI
11	McClure R, Balasubramanian D, Sun Y, Bobrovskyy M, Sumby P, Genco CA, Vanderpool CK and Tjaden B: Computational analysis of bacterial RNA-Seq data. Nucleic Acids Res. 41:e1402013. View Article : Google Scholar : PubMed/NCBI
12	Bolger AM, Lohse M and Usadel B: Trimmomatic: A flexible trimmer for Illumina sequence data. Bioinformatics. 30:2114–2120. 2014. View Article : Google Scholar : PubMed/NCBI
13	Langmead B and Salzberg SL: Fast gapped-read alignment with Bowtie 2. Nat Methods. 9:357–359. 2012. View Article : Google Scholar : PubMed/NCBI
14	Robinson JT, Thorvaldsdóttir H, Winckler W, Guttman M, Lander ES, Getz G and Mesirov JP: Integrative genomics viewer. Nat Biotechnol. 29:24–26. 2011. View Article : Google Scholar : PubMed/NCBI
15	Quinlan AR and Hall IM: BEDTools: A flexible suite of utilities for comparing genomic features. Bioinformatics. 26:841–842. 2010. View Article : Google Scholar : PubMed/NCBI
16	Robinson MD and Oshlack A: A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 11:R252010. View Article : Google Scholar : PubMed/NCBI
17	Huang da W, Sherman BT and Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
18	Gene Ontology Consortium: Gene ontology consortium: Going forward. Nucleic Acids Res 43 (Database Issue). D1049–D1056. 2015. View Article : Google Scholar
19	Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos A, Tsafou KP, et al: STRING v10: Protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res 43 (Database Issue). D447–D452. 2015. View Article : Google Scholar
20	Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
21	Opsahl T, Agneessens F and Skvoretz J: Node centrality in weighted networks: Generalizing degree and shortest paths. Soc Netw. 32:245–251. 2010. View Article : Google Scholar
22	Cukierski WJ and Foran DJ: Using betweenness centrality to identify manifold shortcuts. Proc IEEE Int Conf Data Min. 2008:949–958. 2008.PubMed/NCBI
23	Du Y, Gao C, Chen X, Hu Y, Sadiq R and Deng Y: A new closeness centrality measure via effective distance in complex networks. Chaos. 25:0331122015. View Article : Google Scholar : PubMed/NCBI
24	Tang Y, Li M, Wang J, Pan Y and Wu FX: CytoNCA: A cytoscape plugin for centrality analysis and evaluation of protein interaction networks. Biosystems. 127:67–72. 2015. View Article : Google Scholar : PubMed/NCBI
25	Safari-Alighiarloo N, Taghizadeh M, Rezaei-Tavirani M, Goliaei B and Peyvandi AA: Protein-protein interaction networks (PPI) and complex diseases. Gastroenterol Hepatol Bed Bench. 7:17–31. 2014.PubMed/NCBI
26	Bader GD and Hogue CW: An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics. 4:22003. View Article : Google Scholar : PubMed/NCBI
27	Sankaran B, Bonnett SA, Shah K, Gabriel S, Reddy R, Schimmel P, Rodionov DA, de Crécy-Lagard V, Helmann JD, Iwata-Reuyl D and Swairjo MA: Zinc-independent folate biosynthesis: Genetic, biochemical, and structural investigations reveal new metal dependence for GTP cyclohydrolase IB. J Bacteriol. 191:6936–6949. 2009. View Article : Google Scholar : PubMed/NCBI
28	Rebelo J, Auerbach G, Bader G, Bracher A, Nar H, Hösl C, Schramek N, Kaiser J, Bacher A, Huber R and Fischer M: Biosynthesis of pteridines. Reaction mechanism of GTP cyclohydrolase I. J Mol Biol. 326:503–516. 2003. View Article : Google Scholar : PubMed/NCBI
29	Babitzke P, Gollnick P and Yanofsky C: The mtrAB operon of Bacillus subtilis encodes GTP cyclohydrolase I (MtrA), an enzyme involved in folic acid biosynthesis, and MtrB, a regulator of tryptophan biosynthesis. J Bacteriol. 174:2059–2064. 1992. View Article : Google Scholar : PubMed/NCBI
30	Bermingham A and Derrick JP: The folic acid biosynthesis pathway in bacteria: Evaluation of potential for antibacterial drug discovery. Bioessays. 24:637–648. 2002. View Article : Google Scholar : PubMed/NCBI
31	Rengarajan J, Sassetti CM, Naroditskaya V, Sloutsky A, Bloom BR and Rubin EJ: The folate pathway is a target for resistance to the drug para-aminosalicylic acid (PAS) in mycobacteria. Mol Microbiol. 53:275–282. 2004. View Article : Google Scholar : PubMed/NCBI
32	Pan FL and Coote JG: Glutamine synthetase and glutamate synthase activities during growth and sporulation in Bacillus subtilis. J Gen Microbiol. 112:373–377. 1979. View Article : Google Scholar : PubMed/NCBI
33	Harth G, Zamecnik PC, Tang JY, Tabatadze D and Horwitz MA: Treatment of Mycobacterium tuberculosis with antisense oligonucleotides to glutamine synthetase mRNA inhibits glutamine synthetase activity, formation of the poly-L-glutamate/glutamine cell wall structure, and bacterial replication. Proc Natl Acad Sci USA. 97:418–423. 2000. View Article : Google Scholar : PubMed/NCBI
34	Harth G and Horwitz MA: An inhibitor of exported Mycobacterium tuberculosis glutamine synthetase selectively blocks the growth of pathogenic mycobacteria in axenic culture and in human monocytes: Extracellular proteins as potential novel drug targets. J Exp Med. 189:1425–1436. 1999. View Article : Google Scholar : PubMed/NCBI
35	Utaida S, Dunman PM, Macapagal D, Murphy E, Projan SJ, Singh VK, Jayaswal RK and Wilkinson BJ: Genome-wide transcriptional profiling of the response of Staphylococcus aureus to cell-wall-active antibiotics reveals a cell-wall-stress stimulon. Microbiology. 149:2719–2732. 2003. View Article : Google Scholar : PubMed/NCBI
36	Schnell R, Sandalova T, Hellman U, Lindqvist Y and Schneider G: Siroheme- and [Fe4-S4]-dependent NirA from Mycobacterium tuberculosis is a sulfite reductase with a covalent Cys-Tyr bond in the active site. J Biol Chem. 280:27319–27328. 2005. View Article : Google Scholar : PubMed/NCBI
37	Bhattacharyya S, Saha S, Giri K, Lanza IR, Nair KS, Jennings NB, Rodriguez-Aguayo C, Lopez-Berestein G, Basal E, Weaver AL, et al: Cystathionine beta-synthase (CBS) contributes to advanced ovarian cancer progression and drug resistance. PLoS One. 8:e791672013. View Article : Google Scholar : PubMed/NCBI
38	Bisht R, Katiyar A, Singh R and Mittal P: Antibiotic resistance-A global issue of concern. Asian J Pharm Clin Res. 2:34–39. 2009.
39	Bhave DP, Muse WB III and Carroll KS: Drug targets in mycobacterial sulfur metabolism. Infect Disord Drug Targets. 7:140–158. 2007. View Article : Google Scholar : PubMed/NCBI